Fortis Advisors’s Tenet Healthcare THC Stock Holding History

Fortis Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,584	Closed	-$161K	–	358
2019 Q1	$161K	Buy	+5,584	New	+$138K	0.08%	133

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Fortis Advisors's THC Position: Q2 2019 in Review

Fortis Advisors sold out of Tenet Healthcare (THC) in Q2 2019, closing a stake of 5,584 shares — an estimated $161K sold.

Fortis Advisors first reported a position in THC in Q1 2019 and held it in 1 quarter. The position peaked at $161K in Q1 2019. 245 funds tracked by Wall St. Rank hold THC as of Q2 2019.

Fortis Advisors reported no remaining Tenet Healthcare position as of Q2 2019 after selling out during the quarter.
Fortis Advisors sold 5,584 Tenet Healthcare shares in Q2 2019, an estimated $161K.
Fortis Advisors first reported a position in Tenet Healthcare in Q1 2019 and held it in 1 quarter.
Fortis Advisors's Tenet Healthcare position peaked at $161K in Q1 2019.
245 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2019.

Based on Fortis Advisors's 13F filing for Q2 2019, filed 12 Aug 2019.